Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB

Question

Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB:

Anonymous · Answer

Must occur within 12 months of the approval date.

1 Answer